SIGNA Prime Elite

The SIGNA Prime Elite is a whole-body magnetic resonance scanner designed for advanced diagnostic imaging, leveraging technology to achieve high-resolution and high signal-to-noise ratio images with short scan times. Its substantial equivalence for market approval was established through rigorous non-clinical testing and comparison to existing devices, demonstrating its safety and performance capabilities across diverse anatomical regions.

The SIGNA Prime Elite, a whole-body magnetic resonance scanner from GE Medical Systems, LLC, has received a determination of substantial equivalence, allowing its marketing as a legally available diagnostic device. This regulatory approval, communicated on March 17, 2025, to Glen Sabin, Director of Regulatory Affairs for MR Strategy, signifies that the device is deemed equivalent to other MR diagnostic devices already on the market, affirming its suitability for clinical use. Designed for diagnostic imaging, the SIGNA Prime Elite is engineered to produce high-resolution, high signal-to-noise ratio images with reduced scan times across the entire body, including the head, spine, heart, and musculoskeletal regions. The basis for the substantial equivalence determination included comprehensive non-clinical testing to validate its safety and performance, adherence to relevant industry standards, and a direct comparison of its technological specifications and intended uses against a previously cleared device. Ongoing compliance with manufacturing quality, labeling, and adverse event reporting regulations is required.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific quantitative metrics demonstrate the 'high-resolution' and 'high signal-to-noise ratio' claims compared to the predicate device?; Could you detail the specific non-clinical tests and their outcomes that supported the safety and performance claims for various anatomical regions?; What are the typical scan times achieved for different whole-body applications, and how do these contribute to patient throughput and comfort?; Are there any specific imaging sequences or advanced capabilities unique to the SIGNA Prime Elite that differentiate it from other diagnostic MR scanners?; What post-market surveillance or clinical trial plans are in place to further validate the device's performance and impact on diagnostic accuracy in a clinical setting?